Perphenazine

Subject areas

This course counts toward the state boards and subject areas below.

Disclosure statements

Policy Statement

This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and the continuing nursing education requirements of the American Nurses Credentialing Center's Commission on Accreditation for registered nurses.

Continuing Education Credit Designation

This educational activity is credited for 2.5 hours at completion of the activity. Pharmacology content is 2.5 hours.

Statement of Learning Need

Health clinicians need to know the indications, uses, contraindications and potential side effects of perphenazine to provide safe and appropriate patient care. Warnings for perphenazine use should be shared with patients and families, such as use related to care of elderly patients with dementia and those with cognitive disabilities or other comorbid conditions. Also, clinicians should always bear in mind short- and long-term use of perphenazine when prescribing it as monotherapy on in conjunction with other medication. 

Course Purpose

To inform health clinicians of current published information relative to basic pharmacological profile of perphenazine and clinical pearls to help elucidate the current research and case studies relative to the benefits and risks of perphenazine drug use.

Target Audience

Advanced Practice Registered Nurses, Registered Nurses, and other Interdisciplinary Health Team Members.

Disclosures

Dana Bartlett, RN, BSN, MSN, MA, CSPI, William Cook, PhD, Douglas Lawrence, MA, Susan DePasquale, MSN, FPMHNP-BC – all have no disclosures. There is no commercial support for this course.

Learner Feedback